There is a paucity of information regarding the epidemiology and outcome of COVID-19 from low/middleincome countries, including from Nigeria. This single-center study described the clinical features, laboratory findings, and predictors of in-hospital mortality of COVID-19 patients. Patients admitted between April 10, 2020 and June 10, 2020 were included. Forty-five patients with a mean age of 43 (16) years, predominantly male (87%), presented with fever (38%), cough (29%), or dyspnea (24%). In-hospital mortality was 16%. The independent predictors of mortality were hypoxemia (adjusted odds ratio [aOR]: 2.5; 95% CI: 1.3-5.1) and creatinine > 1.5 mg/dL (aOR: 4.3; 95% CI: 1.9-9.8).
Introduction The global spread of COVID-19 remains unabated in the past few months with a rise in the number of available literature on the novel virus. There are very few paediatric studies and are mainly from developed countries with a paucity of information on the clinical manifestation of COVID-19 disease in African children, including Nigeria. Methods We described the clinical presentation, laboratory findings, treatment and outcome in a group of five Nigerian children managed at a COVID-19 isolation and treatment centre in Nigeria. Results We managed a total of five children with an age range of 3 months to 8 years in the last four weeks (16th April to 15th May 2020). Three of the five children were males. All the children had close contact with family members that tested positive for COVID-19. Out of the five children, one had moderate disease, three had mild symptomatic disease, and one was asymptomatic. Two out of the five children had lymphocytosis. Out of the four children who had chest radiograph, two had features of pneumonia. Conclusion COVID-19 is not uncommon in Nigerian children, and all had a confirmed family member with COVID-19. Besides, contrary to leucopaenia with lymphopaenia observed in the adult’s population, we found lymphocytosis in this cohort and about 50.0% had pneumonic changes on chest radiograph.
Introduction: Bullying victimization is a common experience among adolescents. Victimization is associated with negative consequences including negative mental outcomes, poor academic results, and poor social relationships. We describe the various forms of bullying victimization and the predictors of victimization among in-school adolescents in Sokoto metropolis. Material and Methods:We conducted a cross-sectional study among in-school adolescents in Sokoto metropolis. Using a multistage sampling technique, 450 respondents were selected from public and private schools We used an adapted, validated, pretested and interviewer-administered peer victimization scale questionnaire to collect information from respondents. We conducted a descriptive statistic, bivariate and multivariate analysis at 5% level of significance.Results: Of the 450 respondents, 182 (40.4%) were in early adolescence and 220 (48.9%) were females. The mean age of respondents was 15.2 ± 1.9 years. Two hundred and thirty (51.1%), 102 (22.7%), 38 (8.4%), 161 (35.8) respondents had experienced physical, verbal, relational and damage-toproperty victimization respectively. Overall, 295 (65.6%) had experienced at least one type of bullying victimization. Being in junior class (adjusted odds ratio (aOR): 2.1, 95% CI= 1.2-3.5) being in a boarding school (aOR: 3.4, 95% CI= 1.7-6.8), having friends that influence decisions (aOR: 2.5 (1.1-5.6), not smoking (aOR: 3.3, 95% CI = 1.1-10.0) and not knowing school policy on bullying (aOR: 2.1, 95% CI= 1.2-3.8) were independent predictors of bullying victimization. Conclusion:There is a high prevalence of bullying victimization among in-school adolescents in Sokoto metropolis. We recommend that school policy should protect junior students and those in boarding schools from victimization.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.